Skip to main content
. Author manuscript; available in PMC: 2009 Jul 4.
Published in final edited form as: Vaccine. 2008 May 19;26(29-30):3617–3625. doi: 10.1016/j.vaccine.2008.04.080

Table 2.

Egg burden (mean ± SE) in immunized and control water buffaloes in trials 1 and 2, and percent reduction in egg burden in immunized animals compared with their corresponding control group (pVAX) in each trial.

Group Eggs per gram liver
Eggs per gram feces
Hatched miracidia per gram feces
Mean ± SE Vaccine Efficacy (%)a, (95% CI) Mean ± SE Vaccine Efficacy (%)a, (95% CI) Mean ± SE Vaccine Efficacy (%)a, (95% CI)
Trial 1
  pVAX 459.0 ± 25.6 --- 23.8 ± 1.7 --- 18.4 ± 1.6 ---
  (n = 15)
  SjCTPI 266.4 ± 24.2 42.0% 14.7 ± 1.3 38.3% 12.3 ± 1.1 33.2%
  (n = 13) (30.4%, 51.6%) (24.6%, 49.4%) (16.2%, 46.7%)b
  SjCTPI-Hsp70 177.0 ± 11.5 61.5% 11.4 ± 0.7 52.1% 8.8 ± 0.7 52.1%
  (n = 15) (54%, 67.7%) (41.3%, 60.9%) (39.4%, 62.2%)
Trial 2
  pVAX 500.1 ± 26.5 --- 32.5 ± 2.1 --- 26.5 ± 1.0 ---
  (n = 13)
  SjC23 285.7 ± 21.7 42.9% 19.5 ± 0.9 40.2% 13.9 ± 0.6 47.4%
  (n = 15) (32.3%, 51.8%) (30.0%, 48.9%) (37.1%, 56.0%)
  SjC23-Hsp70 230.6 ± 13.6 53.9% 16.9 ± 0.8 48.0% 12.7 ± 0.7 52.0%
  (n = 15) (45.6%, 60.9%) (39.1%, 55.5%) (42.8%, 59.7%)
a

Percent reduction in egg burdens were significant at p<0.0001;

b

significant at p< 0.001; CI: 95% confidence intervals. n represents the number of animals in each group at the time of perfusion.